Interpectoral-pectoserratus Plane Block for Minimally Invasive Aortic Valve Replacement Via Right Anterior Minithoracotomy

PHASE4RecruitingINTERVENTIONAL
Enrollment

144

Participants

Timeline

Start Date

September 1, 2024

Primary Completion Date

November 30, 2027

Study Completion Date

December 31, 2027

Conditions
Analgesic Effect
Interventions
DRUG

Levobupivacaine Hydrochloride 0.25 % Injectable Solution

After wound closure, the IPP-PSP block is performed at the level of the 4th rib. At the pre-axillary line, the pectoralis major, the pectoralis minor and the serratus anterior muscle are identified. At first, the needle is positioned in the fascial plane between the pectoralis minor and the serratus anterior muscle. The needle position is confirmed by hydro-dissection of this plane with 2 mL of normal saline 0.9%.The 20 ml syringe with trial drug solution is injected in this pectoserratus plane (PSP). The needle tip is repositioned in the interpectoral plane between both the pectoralis major and minor muscle. The 10 ml syringe with trial drug solution is administered in this interpectoral plane (IPP).

DRUG

Sodium chloride 0.9%

Unilateral (right) IPP-PSP block with 30 mL normal saline 0.9%, administered after the closure of the wounds. The IPP-PSP block procedure will be carried out as described in the intervention description of the IPP-PSP block.

Trial Locations (1)

9000

RECRUITING

AZ Maria Middelares, Ghent

All Listed Sponsors
lead

Algemeen Ziekenhuis Maria Middelares

OTHER

NCT06369870 - Interpectoral-pectoserratus Plane Block for Minimally Invasive Aortic Valve Replacement Via Right Anterior Minithoracotomy | Biotech Hunter | Biotech Hunter